Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 80,000 shares at $33.17 ($2.7M) on 2024-06-12, disclosed to the SEC on 2024-06-13.
Scheduled sale ($2.7M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.17 | 26,036 | $864K | 32.4% |
| 2 | $33.17 | 26,036 | $864K | 32.4% |
| 3 | $33.70 | 13,964 | $471K | 17.6% |
| 4 | $33.70 | 13,964 | $471K | 17.6% |
| Total | $33.36 avg | 80,000 | $2.7M | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |